Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2001
DOI: 10.1124/mol.59.5.1165
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of Nuclear Factor κB in c-Myc Induction by Tubulin Polymerization Inhibitors

Abstract: We showed previously that microtubule disassembly by vinblastine induces the proto-oncogene c-myc in epithelial mammary HBL100 cells. In this study, we demonstrate that vinblastine treatment in these cells, in contrast to what was observed with the colon adenocarcinoma cell line HT29-D4, activated the transcription factor NFkappaB, which has been involved in c-myc regulation. The microtubule disassembly also induced IkappaB degradation. Using transient transfection analysis, we show that the trans-activation o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
34
0
2

Year Published

2002
2002
2010
2010

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(39 citation statements)
references
References 43 publications
3
34
0
2
Order By: Relevance
“…Indeed, depolymerization of microtubules leads to activation of NFκB, while microtubule stabilization by taxol has an inhibitory effect on NFκB in human cervix carcinoma HeLa S3 cells 6 . This is in agreement with the observation that vinblastine and nocodazole transactivate c-myc in epithelial mammary cells HBL100 via NFκB activation whereas taxol has no effect 7 . Moreover, the fact that microtubule disarray leads to the activation of c-jun Nterminal kinase (JNK) 8 , which in turn activates the c-jun subunit of the AP-1 transcription factor, together with the finding that activation of JNK results in phosphorylation and subsequent inactivation of rat GR 9 we hypothesise that JNK may participate in hGR activity regulation by microtubule disruption.…”
Section: Introductionsupporting
confidence: 92%
“…Indeed, depolymerization of microtubules leads to activation of NFκB, while microtubule stabilization by taxol has an inhibitory effect on NFκB in human cervix carcinoma HeLa S3 cells 6 . This is in agreement with the observation that vinblastine and nocodazole transactivate c-myc in epithelial mammary cells HBL100 via NFκB activation whereas taxol has no effect 7 . Moreover, the fact that microtubule disarray leads to the activation of c-jun Nterminal kinase (JNK) 8 , which in turn activates the c-jun subunit of the AP-1 transcription factor, together with the finding that activation of JNK results in phosphorylation and subsequent inactivation of rat GR 9 we hypothesise that JNK may participate in hGR activity regulation by microtubule disruption.…”
Section: Introductionsupporting
confidence: 92%
“…Although the hTERT promoter contains two putative NFkBbinding motifs, no DNA binding was observed (Yin et al, 2000). Therefore, NFkB may regulate hTERT expression via c-Myc because c-Myc is a downstream target of NFkB (Bourgarel-Rey et al, 2001) that upregulates hTERT transcription. It was reported previously that estrogen activates c-Myc expression, and that E-boxes in the hTERT promoter that bind cMyc/Max play additional roles in estrogen-induced transactivation of hTERT (Kyo et al, 1999c).…”
Section: Discussionmentioning
confidence: 99%
“…In the promoter of the proto-oncogene c-myc there are two B sites (44) indicating that NF-B can regulate c-myc. In human colon adenocarcinoma cells, vinblastine and nocodonazole, both inhibitors of tubulin polymerization, lead to NF-B activation (45). The vinblastineinduced transactivation of c-myc is partially dependent on NF-B as mutations in the B sites decrease the capacity of vinblastine to stimulate the transactivation of c-myc.…”
Section: Discussionmentioning
confidence: 99%